Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Illumina Inc Signs Definitive Agreement To Acquire Verinata Health, Inc


Monday, 7 Jan 2013 12:00am EST 

Illumina Inc announced that it has signed a definitive agreement to acquire Verinata Health, Inc., a provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for consideration of $350 million plus up to $100 million in milestone payments through 2015. Upon completion of the acquisition, Illumina will have access to Verinata‚Äôs verifi prenatal test, the broadest non-invasive prenatal test (NIPT) available for high-risk pregnancies. 

Company Quote

191.12
-2.3 -1.19%
3:16pm EDT